Financials
Financial year 2024
DIGESTIVE DISEASE CENTER from Ganshoren, company number BE0875157457, closed financial year 2024 with a result of € 178,473 after tax. For that financial year DIGESTIVE DISEASE CENTER recorded a gross margin of € 302,993 and equity of € 76,650. Compared with financial year 2023, the result moved from € 593 to € 178,473. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2025.
€ 76,650
▲ € 178,473 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 178,473
▲ € 177,880 vs 2023
Profit after tax over the fiscal year.
€ 73,015
▲ € 72,936 vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 58,050.
People and assets in 2024
€ 116,279
▲ 37% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 358
▼ 37% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 52,190
▲ 2% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 15,333
▲ 9% vs 2023
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 101,721 | € 77,670 | € 90,184 | € 302,993 | ▲ 236% |
| Profit after taxes | € -6,176 | € -26,922 | € 593 | € 178,473 | ▲ € 177,880 |
| Equity | € -75,494 | € -102,417 | € -101,824 | € 76,650 | ▲ € 178,473 |
| Total debts | € 114,770 | € 152,055 | € 158,916 | € 124,512 | ▼ 22% |
| Cash | € 1,078 | - | € 79 | € 73,015 | ▲ € 72,936 |
| Retained profit | € -94,094 | € -121,017 | € -120,424 | € 58,050 | ▲ € 178,473 |
| Bank debt | € 26,919 | € 40,442 | € 37,483 | € 0 | ▼ 100% |
| Balance sheet total | € 39,276 | € 49,638 | € 57,093 | € 201,162 | ▲ 252% |
Key figures of DIGESTIVE DISEASE CENTER, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to DIGESTIVE DISEASE CENTER?
What happened at DIGESTIVE DISEASE CENTER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 178,473 (▲ € 177,880 vs 2023). filed late Source: NBB ↗
- CLAUDE JONAS became a director. NBB
- JULIO OTERO became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Ganshoren. KBO
In short
From € 6,176 loss in 2021 to € 178,473 profit in 2024.
Paid € 1,857 in corporate taxes since 2021.
Best year ever: 2024, with € 178,473 profit.
A new publication or filing at DIGESTIVE DISEASE CENTER? We notify you, reason included.
Follow DIGESTIVE DISEASE CENTERDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DIGESTIVE DISEASE CENTER are CLAUDE JONAS and JULIO OTERO. CLAUDE JONAS is also behind GASTRO DIAGNOSIS & RESEARCH. JULIO OTERO is also behind GASTRO MEDICAL ASSISTANCE.
Directors
According to the 2024 annual accounts
since 2014
since 2014
Establishments
Establishment units
Physical locations of this company
François Beeckmansstraat 5
1083 Ganshoren
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0875.157.457
- VAT number
- BE 0875.157.457
- Registered office
- François Beeckmansstraat 5, 1083 Ganshoren
- Names & denominations
- DIGESTIVE DISEASE CENTER · DDC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 July 2005
- Peppol
- Active · Active since 5 Jan 2026
- Activities · NACE
Activiteiten van medisch specialisten
Medische praktijken